Literature DB >> 1457492

Do self-reported arthritis symptom (RADAR) and health status (AIMS2) data provide duplicative or complementary information?

J H Mason, R F Meenan, J J Anderson.   

Abstract

This study assessed whether self-report measures of symptoms and functional health status provide unique outcome information, or whether functional status assessments primarily serve as a proxy for self-reported arthritis symptoms. Symptom scores of 138 individuals with rheumatoid arthritis (RA) collected with the Rapid Assessment of Disease Activity in Rheumatology (RADAR) measure were compared with same-day functional health scores collected with the recently revised Arthritis Impact Measurement Scales (AIMS2). Correlational and factor analyses revealed that self-assessed arthritis symptoms, physical function and work impact, psychological status, and social health each made independent contributions to outcome. Satisfaction with health status was shown not to be independent of symptoms, functional capacity, or psychological status. It is important to document that self-reported symptom and health status information, when collected concurrently, provides complementary rather than duplicative information.

Entities:  

Mesh:

Year:  1992        PMID: 1457492     DOI: 10.1002/art.1790050309

Source DB:  PubMed          Journal:  Arthritis Care Res        ISSN: 0893-7524


  3 in total

Review 1.  Prognostic markers in rheumatoid arthritis and classification of antirheumatic therapies.

Authors:  E H Choy; D L Scott
Journal:  Drugs       Date:  1995       Impact factor: 9.546

2.  Long-term patterns of depression and associations with health and function in a panel study of rheumatoid arthritis.

Authors:  Anne Morris; Edward H Yelin; Pantelis Panopalis; Laura Julian; Patricia P Katz
Journal:  J Health Psychol       Date:  2011-03-18

Review 3.  [Measuring disease activity for rheumatoid arthritis].

Authors:  D Aletaha; T Stamm; J Smolen
Journal:  Z Rheumatol       Date:  2006-03       Impact factor: 1.372

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.